Global Electroencephalography Devices Market is expected to grow with the CAGR of 4.90% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:
Global electroencephalography devices market is a highly consolidated market which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global electroencephalography devices market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, In October 2021, JAMA Network Open published a report on BrainScope Company Inc. BrainScope is assessing the accuracy of the mobile EEG device in accurately indicating the possibility of a concussion due to injury in athletes and their readiness to return to the field. They concluded that this point of care device helps in rapid detection of a possible concussion. The sensitivity of concussion index observed during the study came out to be 86% followed by specificity of 71% which supported the accuracy of the device. This study will help earn even more credibility among the end users and drive the growth of the market.
Medtronic is the dominating player in global electroencephalography devices market. The other key players existing in the electroencephalography devices market includes Cadwell Industries Inc., Compumedics Limited, NeuroWave Systems Inc., Natus Medical Incorporated, NIHON KOHDEN CORPORATION, NeuroSky, Bio-Signal Group Corp., Elekta AB, Lifelines Neuro, Neurosoft S.A., EMS Handels Gesellschaft mbH, Jordan NeuroScience, Inc., BrainScope Company Inc., Advanced Brain Monitoring, Inc., EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, Electrical Geodesics, Inc., Masimo, ELMIKO MEDICAL sp. Z oo, Micromed among others.
Medtronic is headquartered in Dublin, Ireland and was founded in 1949. The company focuses on treatment of various health conditions which include patient monitoring systems, respiratory systems and more by providing products in domains such as cardiovascular, respiratory, diabetes among more. The company deals in multiple business segments such as cardiac and vascular group, minimally invasive therapies group, restorative therapies group and diabetes group out of which restorative therapies group is the market focused segment. The company provides products under categories such as advanced surgical technology, cardiac rhythm, cardiovascular, diabetes, digestive & gastrointestinal, ear, nose & throat, general surgery, gynecological, neurological, oral, maxillofacial & dental, patient monitoring, renal care, respiratory, spinal & orthopaedic, surgical navigation & imaging and urological among which patient monitoring is the market focused category.
The company has presence in North America, South America, Europe, Asia-Pacific and Middle East and Africa. The company has various subsidiaries that are A&E Hangers Taiwan Co., Ltd. (Taiwan), A&E Products Group, Inc. (Delaware), Accucomp (Pty.) Ltd. (Delaware), Airox, Inc. (France) and Arterial Vascular Engineering UK Limited (U.K.) among more.
NIHON KOHDEN CORPORATION:
NIHON KOHDEN CORPORATION is headquartered in Tokyo, Japan and was founded in 1951. The company focuses on manufacturing and distribution of medical equipment for emergency care, home care and health promotion among others. The company deals in multiple business segments such as physiological measuring equipment, patient monitors, treatment equipment and others out of which physiological measuring equipment is the market focused segment. The company provides products under categories such as Nihon Kohden monitoring, Nihon Kohden neurology, Nihon Kohden ventilation solutions and Nihon Kohden cardiology among which Nihon Kohden neurology is the market focused category.
The company has wide global presence across the world in Americas, Europe, Asia-Pacific and Middle East and Africa with its various subsidiaries such as Nihon Kohden America, Inc. (U.S.), Nihon Kohden Mexico S.A. de C.V. (Mexico), Nihon Kohden Europe GmbH (Germany), Nihon Kohden Singapore Pte Ltd (Singapore) and Nihon Kohden Middle East FZE (UAE) among more.
Masimo is headquartered in Irvine, U.S. and was founded in 1989. The company develops and manufactures innovative non-invasive patient monitoring technologies, medical devices and wide array of sensors. The company provides products under categories such as technology, product, solution and clinical evidence among which product is the market focused category.
The company has wide global presence across North America, South America, Europe, Asia-Pacific, Oceania and Middle East and Africa. The company has various subsidiaries such as Masimo Americas, Inc. (Delaware), Masimo de Mexico Holdings I LLC (Delaware), Masimo from Mexico Holdings II LLC (Delaware), Masimo Holdings LLC (Delaware) and Masimo Peru Srl (Peru), among others.
Global Electroencephalography Devices Market – Industry Trends and Forecast to 2029
Europe Electroencephalography Devices Market – Industry Trends and Forecast to 2028
Asia-Pacific Electroencephalography Devices Market – Industry Trends and Forecast to 2028
Middle East and Africa Electroencephalography Devices Market – Industry Trends and Forecast to 2028
North America Electroencephalography Devices Market – Industry Trends and Forecast to 2028